Pharmafile Logo

News and Press Releases

Quidditas raises €2.62M to accelerate development of pioneering genome editing technology

Funding will enable company to expand research capacity and scale up unique genome editing technology designed to treat complex, rare diseases while also opening new avenues for protein bioproduction and...

Category: BioManufacturing, Drug Discovery, Other, Pharmaceutical
Posted: May 12, 2025

Quidditas Therapeutics
contact@quidditastherapeutics.com
23, rue des bourguignons 91310 MONTLHERY

ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement

License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services 1 October 2024 -- Dublin, Ireland, and Montreal, Canada -- ERS Genomics...

Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: October 1, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement

Partnership provides Medicines Discovery Catapult access to CRISPR gene editing technology across a broad range of drug discovery applications 04 September 2024 – Dublin, Ireland, and Cheshire, UK – ERS...

Category: BioManufacturing
Posted: September 9, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering 20 May 2024 -- Dublin, Ireland, and Rome, Italy -- ERS...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: May 20, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

ERS Genomics appoints John E Milad as Chief Executive Officer

13 May 2024 -- Dublin, Ireland -- ERS Genomics, the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25...

Category: Drug Delivery, Drug Discovery
Posted: May 13, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template

9 May 2024 -- Hampton, UK -- Touchlight Genetics, in partnership with the National Physical Laboratory (NPL), have secured funding from Innovate UK under their Innovative Technologies: Nucleic Acid Medicines...

Category: Biotechnology
Posted: May 10, 2024

Touchlight
info@touchlight.com
Morelands & Riverdale Buildings Lower Sunbury Road Hampton TW12 2ER

Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement

CRISPR/Cas9 genome editing technology contributes to the expansion of the creation of novel disease model 13 March 2024 -- Tokyo, Japan, and Dublin, Ireland -- Ricoh Company today announced a...

Category: Biotechnology
Posted: March 13, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland